1-1020221-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_198576.4(AGRN):c.49C>T(p.Leu17Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000565 in 1,415,326 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_198576.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AGRN | NM_198576.4 | c.49C>T | p.Leu17Phe | missense_variant | 1/36 | ENST00000379370.7 | NP_940978.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AGRN | ENST00000379370.7 | c.49C>T | p.Leu17Phe | missense_variant | 1/36 | 1 | NM_198576.4 | ENSP00000368678 | P1 | |
AGRN | ENST00000620552.4 | c.-366C>T | 5_prime_UTR_variant | 1/39 | 5 | ENSP00000484607 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151640Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000325 AC: 2AN: 61450Hom.: 0 AF XY: 0.0000554 AC XY: 2AN XY: 36108
GnomAD4 exome AF: 0.00000475 AC: 6AN: 1263686Hom.: 0 Cov.: 32 AF XY: 0.00000643 AC XY: 4AN XY: 621800
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151640Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74090
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Sep 07, 2016 | The L17F variant in the AGRN gene has not been reported previously as a pathogenic variant, nor asa benign variant, to our knowledge. The L17F variant was not observed in approximately 2700individuals of European and African American ancestry in the NHLBI Exome Sequencing Project,indicating it is not a common benign variant in these populations. This substitution occurs at aposition that is conserved in mammals. However, the L17F variant is a conservative amino acidsubstitution, which is not likely to impact secondary protein structure as these residues share similarproperties and in silico analysis predicts this variant likely does not alter the proteinstructure/function. We interpret L17F as a variant of uncertain significance. - |
Congenital myasthenic syndrome 8 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 26, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Not Available"; Align-GVGD: "Class C0"). ClinVar contains an entry for this variant (Variation ID: 388958). This variant has not been reported in the literature in individuals affected with AGRN-related conditions. This variant is present in population databases (no rsID available, gnomAD 0.03%). This sequence change replaces leucine, which is neutral and non-polar, with phenylalanine, which is neutral and non-polar, at codon 17 of the AGRN protein (p.Leu17Phe). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at